Genedata Unveils New Japanese Web Site for Expanding Pharma R&D and Life Science Business
News Nov 16, 2009
Genedata has announced its new Japanese web site (www.genedata.jp), which enhances knowledge sharing related to target discovery and integrated biological data management; high throughput screening and high content screening; and biomarker discovery and personalized medicine.
The new Japanese web site closely follows an expansion of Genedata in Japan and supports the growing customer base in Asia. Recently signed customers include Astellas Pharmaceuticals, Asubio, Chugai Pharmaceuticals, Takeda Pharmaceuticals, as well as several other pharmaceutical and biotechnology companies. Academic institutions using Genedata software systems include Hyogo College of Medicine, NCC Japan, RIKEN, and Tokyo University.
The success in Japan correlates directly with the success of Genedata globally; the majority of the top 50 pharmaceuticals use Genedata software systems for large-scale biology applications to improve R&D efficiency.
“We hope that the new Japanese site facilitates easier access to valuable information for our Japanese customers,” said Dr. Othmar Pfannes, CEO of Genedata. “We’ve recently seen significant growth in Japanese business and are committed to further expanding Genedata’s presence in Japan.”
Researchers have developed an artificial enzymatic pathway for synthesizing isoprenoids, or terpenes, in E. coli. This shorter, more efficient, cost-effective and customizable pathway transforms E. coli into a factory that can produce terpenes for use in everything from cancer drugs to biofuels.READ MORE